| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.28B | +1.8% |
| Cost of Revenue | $3.48B | -2.5% |
| R&D Expense | $74.0M | +0.0% |
| SG&A Expense | $847.0M | +0.8% |
| Operating Income | $706.0M | +20.2% |
| Pre-tax Income | $496.0M | +39.8% |
| Income Tax | $105.0M | +21.8% |
| Net Income | $391.0M | +46.2% |
| EPS (Basic) | $1.78 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $593.0M | -15.3% |
| Accounts Receivable | $1.01B | -2.7% |
| Inventory | $734.0M | -1.0% |
| Current Assets | $2.72B | -3.5% |
| Total Assets | $7.25B | -0.3% |
| Current Liabilities | $1.35B | -5.1% |
| Long-term Debt | $3.40B | -2.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $576.0M | +0.1% |
| Capital Expenditures | $140.0M | +1.5% |
| Investing Cash Flow | -$440.0M | -113.9% |
| Financing Cash Flow | -$201.0M | +36.2% |
| Free Cash Flow | $436.0M | -0.3% |
| +47.1% |
| EPS (Diluted) | $1.78 | +47.1% |
| Total Liabilities |
| $5.29B |
| -3.8% |
| Stockholders' Equity | $1.91B | +10.7% |